We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spire Healthcare Group Plc | LSE:SPI | London | Ordinary Share | GB00BNLPYF73 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
9.50 | 3.98% | 248.00 | 247.50 | 249.00 | 251.00 | 240.00 | 240.00 | 3,833,391 | 16:35:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 1.36B | 27.3M | 0.0676 | 36.76 | 1B |
TIDMSPI TIDM42SB
RNS Number : 7080X
Spire Healthcare Group PLC
23 February 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or the underlying Spire Healthcare Group plc issuer of existing shares to which voting rights are attached: (ii) ---------------------------------------------------------------------------- ----------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights -------------------------------------------------------------------------------- ------------------------------- An acquisition or disposal of qualifying financial instruments X which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------------------- ------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------------------- ------------------------------- An event changing the breakdown of voting rights -------------------------------------------------------------------------------- ------------------------------- Other (please specify): ------------------------------------------------------------------------ ------ ------------------------------- 3. Full name of person(s) subject The Goldman Sachs Group, Inc. to the notification obligation: (iii) -------------------------------------------------------------------------- ------------------------------------- 4. Full name of shareholder(s) Goldman Sachs International (if different from 3.):(iv) GS Investment Strategies, LLC -------------------------------------------------------------------------- ------------------------------------- 5. Date of the transaction and date 20 February 2017 on which the threshold is crossed or reached: (v) -------------------------------------------------------------------------- ------------------------------------- 6. Date on which issuer notified: 22 February 2017 -------------------------------------------------------------------------- ------------------------------------- 7. Threshold(s) that is/are crossed Below 3% or reached: (vi, vii) -------------------------------------------------------------------------- ------------------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------ Class/type of Situation previous Resulting situation after the triggering shares to the triggering transaction transaction if possible using the ISIN CODE ---------------- ---------------------------- ------------------------------------------------------------ Number Number Number Number of voting % of voting rights of of of shares rights (x) Shares Voting Rights ---------------- ------------- ------------- ----------- ---------------------- ----------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ---------------- ------------- ------------- ----------- ------- ------------- ------- -------------- GB00BNLPYF73 6,946,370 6,946,370 Below 3% Below 3% ------------- ------------- ----------- ------- ------------- ------- -------------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------ Type of Expiration Exercise/ Number of voting % of voting financial date (xiii) Conversion Period rights that may rights instrument (xiv) be acquired if the instrument is exercised/ converted. ---------------- ------------- -------------------------- ---------------------- ----------------------- Below 3% Below 3% ---------------- ------------- -------------------------- ---------------------- ----------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of % of voting rights financial price date Conversion voting (xix, xx) instrument period rights instrument refers to ------------- --------- ----------- ------------ ------------ --------------------- Nominal Delta ------------- --------- ----------- ------------ ------------ ----------- -------- ------------------------------------------------------------------------------------------------------------ Total (A+B+C) ------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights ---------------------------------------------- ------------------------------------------------------------ Below 3% Below 3% ---------------------------------------------- ------------------------------------------------------------ 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------------------------------------------- N/A Proxy Voting: -------------------------------------------------------------------------------------------------------- 10. Name of the proxy holder: N/A ---------------------------------------------------------------------- -------------------------------- 11. Number of voting rights proxy holder will N/A cease to hold: ---------------------------------------------------------------------- -------------------------------- 12. Date on which proxy holder will cease to N/A hold voting rights: ---------------------------------------------------------------------- -------------------------------- 13. Additional information: General email contact: shareholderdisclosures@gs.com ---------------------------------------------------------------------- -------------------------------- 14. Contact name: Joanna Foley ---------------------------------------------------------------------- -------------------------------- 15. Contact telephone number: +44 207 051 9996 ---------------------------------------------------------------------- --------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUORORBWAUUAR
(END) Dow Jones Newswires
February 23, 2017 08:12 ET (13:12 GMT)
1 Year Spire Healthcare Chart |
1 Month Spire Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions